The Evolution of Clinical Trials in Oncology: Defining Who Benefits from New Drugs Using Innovative Study Designs

Historically, advocates of randomized drug treatment trials in oncology contributed to the changing paradigm for testing cancer treatments in the U.S., which led to global efforts to generate evidence of promise in preclinical model systems and translate those findings into improved patient outcomes...

Descripción completa

Detalles Bibliográficos
Autores principales: Goldberg, Richard M., Wei, Lai, Fernandez, Soledad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AlphaMed Press 2017
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5599203/
https://www.ncbi.nlm.nih.gov/pubmed/28620092
http://dx.doi.org/10.1634/theoncologist.2017-0153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5599203/
https://www.ncbi.nlm.nih.gov/pubmed/28620092
http://dx.doi.org/10.1634/theoncologist.2017-0153

Ejemplares similares